The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Extended Release Drug Market Research Report 2025
Synopsis
Drug delivery systems are engineered technologies for controlled release of drugs or to the targeted delivery of drugs. Drug delivery system is a kind of formulation that enables the administration of therapeutic agents in the body and improves its safety and efficacy by controlling the time, rate and place of drug release in the body. Most of the conventional oral products of drugs are formulated to release the active ingredient as soon as it is administered. Now the pattern has been changed to modified release dosage forms to achieve better therapeutic target. Extended release drugs is a type of dosage forms which allows a two-fold reduction in frequency of dosage administered in the body.
The global Extended Release Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Extended Release Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extended Release Drug.
Report Scope
The Extended Release Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extended Release Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extended Release Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries
Segment by Type
Sustained Release Drug
Controlled Release Drug
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extended Release Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Drug delivery systems are engineered technologies for controlled release of drugs or to the targeted delivery of drugs. Drug delivery system is a kind of formulation that enables the administration of therapeutic agents in the body and improves its safety and efficacy by controlling the time, rate and place of drug release in the body. Most of the conventional oral products of drugs are formulated to release the active ingredient as soon as it is administered. Now the pattern has been changed to modified release dosage forms to achieve better therapeutic target. Extended release drugs is a type of dosage forms which allows a two-fold reduction in frequency of dosage administered in the body.
The global Extended Release Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Extended Release Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extended Release Drug.
Report Scope
The Extended Release Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Extended Release Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extended Release Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Mallinckrodt
Teva
Johnson & Johnson
Endo Pharmaceuticals
Purdue Pharma
Mylan
Hisamitsu Pharmaceutical
Sun Pharmaceutical Industries
Segment by Type
Sustained Release Drug
Controlled Release Drug
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extended Release Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extended Release Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sustained Release Drug
1.2.3 Controlled Release Drug
1.3 Market by Application
1.3.1 Global Extended Release Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extended Release Drug Market Perspective (2019-2030)
2.2 Extended Release Drug Growth Trends by Region
2.2.1 Global Extended Release Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Extended Release Drug Historic Market Size by Region (2019-2024)
2.2.3 Extended Release Drug Forecasted Market Size by Region (2025-2030)
2.3 Extended Release Drug Market Dynamics
2.3.1 Extended Release Drug Industry Trends
2.3.2 Extended Release Drug Market Drivers
2.3.3 Extended Release Drug Market Challenges
2.3.4 Extended Release Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extended Release Drug Players by Revenue
3.1.1 Global Top Extended Release Drug Players by Revenue (2019-2024)
3.1.2 Global Extended Release Drug Revenue Market Share by Players (2019-2024)
3.2 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Extended Release Drug Revenue
3.4 Global Extended Release Drug Market Concentration Ratio
3.4.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2023
3.5 Extended Release Drug Key Players Head office and Area Served
3.6 Key Players Extended Release Drug Product Solution and Service
3.7 Date of Enter into Extended Release Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extended Release Drug Breakdown Data by Type
4.1 Global Extended Release Drug Historic Market Size by Type (2019-2024)
4.2 Global Extended Release Drug Forecasted Market Size by Type (2025-2030)
5 Extended Release Drug Breakdown Data by Application
5.1 Global Extended Release Drug Historic Market Size by Application (2019-2024)
5.2 Global Extended Release Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Extended Release Drug Market Size (2019-2030)
6.2 North America Extended Release Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Extended Release Drug Market Size by Country (2019-2024)
6.4 North America Extended Release Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extended Release Drug Market Size (2019-2030)
7.2 Europe Extended Release Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Extended Release Drug Market Size by Country (2019-2024)
7.4 Europe Extended Release Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extended Release Drug Market Size (2019-2030)
8.2 Asia-Pacific Extended Release Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Extended Release Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Extended Release Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Extended Release Drug Market Size (2019-2030)
9.2 Latin America Extended Release Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Extended Release Drug Market Size by Country (2019-2024)
9.4 Latin America Extended Release Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extended Release Drug Market Size (2019-2030)
10.2 Middle East & Africa Extended Release Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Extended Release Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Extended Release Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Extended Release Drug Introduction
11.1.4 Pfizer Revenue in Extended Release Drug Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Mallinckrodt
11.2.1 Mallinckrodt Company Detail
11.2.2 Mallinckrodt Business Overview
11.2.3 Mallinckrodt Extended Release Drug Introduction
11.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2019-2024)
11.2.5 Mallinckrodt Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Extended Release Drug Introduction
11.3.4 Teva Revenue in Extended Release Drug Business (2019-2024)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Extended Release Drug Introduction
11.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Endo Pharmaceuticals
11.5.1 Endo Pharmaceuticals Company Detail
11.5.2 Endo Pharmaceuticals Business Overview
11.5.3 Endo Pharmaceuticals Extended Release Drug Introduction
11.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2019-2024)
11.5.5 Endo Pharmaceuticals Recent Development
11.6 Purdue Pharma
11.6.1 Purdue Pharma Company Detail
11.6.2 Purdue Pharma Business Overview
11.6.3 Purdue Pharma Extended Release Drug Introduction
11.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2019-2024)
11.6.5 Purdue Pharma Recent Development
11.7 Mylan
11.7.1 Mylan Company Detail
11.7.2 Mylan Business Overview
11.7.3 Mylan Extended Release Drug Introduction
11.7.4 Mylan Revenue in Extended Release Drug Business (2019-2024)
11.7.5 Mylan Recent Development
11.8 Hisamitsu Pharmaceutical
11.8.1 Hisamitsu Pharmaceutical Company Detail
11.8.2 Hisamitsu Pharmaceutical Business Overview
11.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction
11.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2019-2024)
11.8.5 Hisamitsu Pharmaceutical Recent Development
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Company Detail
11.9.2 Sun Pharmaceutical Industries Business Overview
11.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction
11.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2019-2024)
11.9.5 Sun Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Sustained Release Drug
Table 3. Key Players of Controlled Release Drug
Table 4. Global Extended Release Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Extended Release Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Extended Release Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Extended Release Drug Market Share by Region (2019-2024)
Table 8. Global Extended Release Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Extended Release Drug Market Share by Region (2025-2030)
Table 10. Extended Release Drug Market Trends
Table 11. Extended Release Drug Market Drivers
Table 12. Extended Release Drug Market Challenges
Table 13. Extended Release Drug Market Restraints
Table 14. Global Extended Release Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Extended Release Drug Market Share by Players (2019-2024)
Table 16. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extended Release Drug as of 2023)
Table 17. Ranking of Global Top Extended Release Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Extended Release Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Extended Release Drug Product Solution and Service
Table 21. Date of Enter into Extended Release Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Extended Release Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Extended Release Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Extended Release Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Extended Release Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Extended Release Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Extended Release Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Extended Release Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Extended Release Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Extended Release Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Extended Release Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Extended Release Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Extended Release Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Extended Release Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Extended Release Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Extended Release Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Extended Release Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Extended Release Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Extended Release Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Extended Release Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Extended Release Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Extended Release Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Extended Release Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Extended Release Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Extended Release Drug Product
Table 49. Pfizer Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Mallinckrodt Company Detail
Table 52. Mallinckrodt Business Overview
Table 53. Mallinckrodt Extended Release Drug Product
Table 54. Mallinckrodt Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 55. Mallinckrodt Recent Development
Table 56. Teva Company Detail
Table 57. Teva Business Overview
Table 58. Teva Extended Release Drug Product
Table 59. Teva Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 60. Teva Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Extended Release Drug Product
Table 64. Johnson & Johnson Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Endo Pharmaceuticals Company Detail
Table 67. Endo Pharmaceuticals Business Overview
Table 68. Endo Pharmaceuticals Extended Release Drug Product
Table 69. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 70. Endo Pharmaceuticals Recent Development
Table 71. Purdue Pharma Company Detail
Table 72. Purdue Pharma Business Overview
Table 73. Purdue Pharma Extended Release Drug Product
Table 74. Purdue Pharma Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 75. Purdue Pharma Recent Development
Table 76. Mylan Company Detail
Table 77. Mylan Business Overview
Table 78. Mylan Extended Release Drug Product
Table 79. Mylan Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 80. Mylan Recent Development
Table 81. Hisamitsu Pharmaceutical Company Detail
Table 82. Hisamitsu Pharmaceutical Business Overview
Table 83. Hisamitsu Pharmaceutical Extended Release Drug Product
Table 84. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 85. Hisamitsu Pharmaceutical Recent Development
Table 86. Sun Pharmaceutical Industries Company Detail
Table 87. Sun Pharmaceutical Industries Business Overview
Table 88. Sun Pharmaceutical Industries Extended Release Drug Product
Table 89. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2019-2024) & (US$ Million)
Table 90. Sun Pharmaceutical Industries Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Extended Release Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Extended Release Drug Market Share by Type: 2023 VS 2030
Figure 3. Sustained Release Drug Features
Figure 4. Controlled Release Drug Features
Figure 5. Global Extended Release Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Extended Release Drug Market Share by Application: 2023 VS 2030
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Extended Release Drug Report Years Considered
Figure 11. Global Extended Release Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Extended Release Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Extended Release Drug Market Share by Region: 2023 VS 2030
Figure 14. Global Extended Release Drug Market Share by Players in 2023
Figure 15. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extended Release Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2023
Figure 17. North America Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Extended Release Drug Market Share by Country (2019-2030)
Figure 19. United States Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Extended Release Drug Market Share by Country (2019-2030)
Figure 23. Germany Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Extended Release Drug Market Share by Region (2019-2030)
Figure 31. China Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Extended Release Drug Market Share by Country (2019-2030)
Figure 39. Mexico Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Extended Release Drug Market Share by Country (2019-2030)
Figure 43. Turkey Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Extended Release Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 46. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 47. Teva Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 49. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 50. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 51. Mylan Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 52. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 53. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
